GrowthCurve Capital buys medication access co TailorMed...

US private equity firm GrowthCurve Capital is acquiring a majority stake in Israeli medication access company TailorMed.

The transaction values the startup at $250 million.

PRO: see who's reacting and what you're missing. See the whole picture →